:,

Markus Arvendell1, Ahmad Abbadi2, Lottie Phillips1

  • 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Urology, Södersjukhuset, Stockholm, Sweden.

European urology focus
|December 27, 2025
PubMed
概括

组织前列腺癌检测 (OPT) 增加了前列腺特异性抗原 (PSA) 检测率. 然而,PSA检测的社会经济差异仍然存在,这表明需要有针对性的战略,以确保公平参与前列腺癌查.